< Back to previous page
Researcher
Elisabeth PICCART
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Other basic sciences not elsewhere classified
Affiliations
- Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Feb 2024 → Today - Biomedical Research Institute (Research institute)
Member
From1 Feb 2024 → Today - Neurosciences (Department)
Member
From1 Feb 2024 → Today - Neurosciences (Research group)
Member
From1 Feb 2024 → Today - Neurosciences (Department)
Member
From1 Jan 2020 → 15 Jan 2024 - Neurosciences (Research group)
Member
From1 Jan 2020 → 15 Jan 2024 - Immunology - Biochemistry (Research group)
Member
From1 Oct 2019 → 31 Dec 2019 - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Jan 2015 → 15 Jan 2024 - Biomedical Research Institute (Research institute)
Member
From1 Jan 2015 → 15 Jan 2024 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Jan 2015 → 31 Dec 2019 - Physiology (Research group)
Member
From1 Jan 2015 → 31 Dec 2019
Projects
1 - 9 of 9
- Enlightening the Glycine Receptor α2 as a key regulator in the brain reward-pathwayFrom1 Nov 2023 → 31 Oct 2025Funding: FWO fellowships
- Enlightening the Glycine Receptor α2 as a key regulator in the brain reward-pathwayFrom1 Nov 2021 → 31 Oct 2023Funding: FWO fellowships
- All you can EAAT3: restoring myelin, the brain's favourite fat.From1 Nov 2020 → 31 Oct 2022Funding: FWO Strategic Basic Research Grant
- Derisking Gebr-32aFrom1 Feb 2020 → 30 Jun 2023Funding: IOF - technology validation in lab
- Boosting myelin production in human pluripotent stem cell-derived oligodendrocytes.From1 Jan 2020 → 31 Dec 2021Funding: Foundations, funds and other with scientific goal
- PDE4D: a novel target in the treatment of progressive multiple sclerosisFrom1 Oct 2019 → 31 Dec 2020Funding: IWT / VLAIO personal funding - innovation mandates
- The glycine alpha 2 receptor: a gatekeeper of the dorsal striatumFrom1 Oct 2019 → 30 Sep 2021Funding: BOF - postdoctoral mandates
- Glycine receptor antagonism in the VTA ameliorates subchronic PCPinduced impairment.From1 Jan 2016 → 31 Dec 2018Funding: FWO research grant KAN
- Glycine receptor antagonism in the VTA ameliorates subchronic PCP-induced impairment.From1 Dec 2015 → 31 Dec 2017Funding: Foundations, funds and other with scientific goal
Publications
1 - 10 of 12
- PDE4D Inhibition with GEBR32A stimulates Schwann cell differentiation and improves the funcional outcome in models for charcot marie tooth disease 1A(2024)Published in: Journal of the peripheral nervous systemISSN: 1085-9489Issue: S3Volume: 29Pages: S165
- The sphingosine-1-phosphate receptor 1 modulator ponesimod repairs cuprizone-induced demyelination and induces oligodendrocyte differentiation(2024)Published in: The Faseb JournalISSN: 0892-6638Issue: 2Volume: 38
- Dopamine-mediated striatal activity and function is enhanced in GlyRa2 knockout animals(2023)Published in: iScienceISSN: 2589-0042Issue: 8Volume: 26
- Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis(2023)Published in: Brain, behavior, and immunityISSN: 0889-1591Volume: 109Pages: 1 - 22
- Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis(2023)Published in: Glia (new York, N.y. : Print)ISSN: 0894-1491Issue: S1Volume: 71Pages: E1089 - E1090
- The Selective Sphingosine-1-Phosphate Receptor 1 (S1P1) Modulator Ponesimod Enhances Murine Oligodendrocyte Precursor Cell (OPC) Differentiation and Retains OPC Migration(2022)Published in: Multiple sclerosisISSN: 1352-4585Issue: S1Volume: 28Pages: 110
- Increasing cAMP levels by inhibiting phosphodiesterase 4D improves nerve conduction and functional recovery in a mouse model for Charcot Marie Toot 1A(2022)Published in: Journal of the peripheral nervous systemISSN: 1085-9489Issue: S3Volume: 27Pages: S139 - S140
- Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders(2021)Published in: Cellular and Molecular Life SciencesISSN: 1420-682XIssue: 10Volume: 78Pages: 4615 - 4637
- PDE inhibition in distinct cell types to reclaim the balance of synaptic plasticity(2021)Published in: TheranosticsISSN: 1838-7640Issue: 5Volume: 11Pages: 2080 - 2097
- Acute and subchronic PCP attenuate D2 autoreceptor signaling in substantia nigra dopamine neurons(2019)Published in: European neuropsychopharmacologyISSN: 0924-977XIssue: 3Volume: 29Pages: 444 - 449